Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.94 |
| ▸ | MAOB | P27338 | 2/20 | 0.94 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.43 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.39 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
| ▸ | OXTR | P30559 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xanthene SCHEMBL27493963 | 0.97 | MAOA (1.00) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL9339684 | 0.97 | MAOA (1.00) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL29378346 | 0.97 | MAOA (1.00) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL30586075 | 0.97 | MAOA (1.00) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL4267 | 0.97 | MAOA (1.00) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL6192065 | 0.94 | MAOA (0.94) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL11600668 | 0.94 | MAOA (0.94) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL1673119 | 0.94 | MAOA (0.94) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL11222980 | 0.94 | MAOA (0.94) | MAOAMAOBGAANPSR1NPC1 | |
| Xanthene SCHEMBL11214757 | 0.94 | MAOA (0.94) | MAOAMAOBGAANPSR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12291548-B2 | Compounds, compositions, and methods for the treatment of disease | SPEROVIE BIOSCIENCES, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| US-20210309692-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | INVOX PHARMA LIMITED (GB) | 2021-10-07 | — | — | US | disclosed |
| EP-3820477-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | Sperovie Biosciences, Inc. (US) | 2021-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309692-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | STING1, MAVS, IRF3 | MAOA 4201/4885MAOB 3689/4885GAA 285/4885 |
| US-12291548-B2 | Compounds, compositions, and methods for the treatment of disease | STING1, MAVS, IRF3 | MAOA 4201/4885MAOB 3689/4885GAA 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.